I-Mab Biopharma
IMAB
#9308
Rank
โ‚ฌ58.83 M
Marketcap
0,71ย โ‚ฌ
Share price
-5.65%
Change (1 day)
-57.71%
Change (1 year)

Revenue for I-Mab Biopharma (IMAB)

Revenue in 2024 (TTM): โ‚ฌ2.96 Million

According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM ) is โ‚ฌ2.87 Million. a decrease over the revenue in the year 2023 that were of โ‚ฌ0.07 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for I-Mab Biopharma from 2017 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 โ‚ฌ0.07 M-139.76%
2022-โ‚ฌ0.2 Million-110.38%
2021โ‚ฌ1.9 M-94.01%
2020 โ‚ฌ31.75 M5798.4%
2019 โ‚ฌ0.53 M-46.01%
2018 โ‚ฌ0.99 M317.83%
2017โ‚ฌ0.23 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.19 M-93.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.62 B 21,690.08%๐Ÿ‡บ๐Ÿ‡ธ USA